Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › ONC
SUPERSTRING CAPITAL MANAGEMENT LP position in ONC
BEONE MEDICINES LTD · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 12,273 shares of ONC (BEONE MEDICINES LTD) in its Q2 2026 13F filing — a position valued at US$3.5M, representing 2.21% of its reported portfolio and ranking #18 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ONC holdings in 3 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's ONC position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in ONC in Q2 2024 at 12,508 shares (US$1.8M). The position peaked in Q2 2026 at 12,273 shares, worth US$3.5M. Across 3 filings, SUPERSTRING CAPITAL MANAGEMENT LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 12,273 shares valued at US$3.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 12.51K | $1.78M | New |
| Q4 2024 | 6.37K | $1.18M | New |
| Q2 2026 | 12.27K | $3.50M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 29 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.43B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.80M sh · $2.51B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 5.01M sh · $1.43B · Q2 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Temasek Holdings (Private) Ltd 845.73K sh · $241.01M · Q2 2026
- Siren, L.L.C. 465.00K sh · $132.51M · Q2 2026
- Capital International, Inc./CA/ 305.48K sh · $87.05M · Q2 2026
- Capital International Sarl 175.54K sh · $50.02M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held ONC?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ONC holdings in 3 of the last 9 reported quarters, going back to Q2 2024.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in ONC?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 12.27K shares of ONC (BEONE MEDICINES LTD), valued at $3.50M, representing 2.21% of its reported portfolio and ranking #18.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling ONC?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP newly opened its position in ONC. The position peaked in Q2 2026 at 12.27K shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.